Test to distinguish bacterial from viral infections

MeMed, Ltd. specializes in advanced diagnostic technologies that leverage machine learning and immunoassay platforms to enhance the management of infectious diseases and inflammatory disorders. Their flagship product, MeMed BV®, is the first FDA-cleared host-immune response assay that distinguishes between bacterial and viral infections within just 15 minutes. This rapid diagnostic capability addresses a critical clinical challenge, as bacterial and viral infections often present similarly, leading to potential mismanagement and unnecessary antibiotic use. The MeMed Key® platform complements this by enabling sensitive, multiplexed protein measurements that were previously limited to larger laboratory settings, thus facilitating quicker and more accurate clinical decision-making.

In addition to MeMed BV® and MeMed Key®, the company is developing a pipeline of products aimed at improving patient outcomes through enhanced diagnostic capabilities. One such product, MeMed Universal Severity™, is designed to assess the likelihood of deterioration in patients with suspected acute infections, providing actionable insights for clinicians. By integrating biomarker measurements with machine learning algorithms, MeMed aims to streamline patient management, reduce clinical workloads, and optimize resource allocation within healthcare systems. The company’s commitment to rigorous clinical validation is evident, with their technologies having been tested in multi-national studies involving over 20,000 patients, ensuring their reliability and effectiveness in diverse clinical settings.

United States

MeMed is a leading med tech and bio-convergence company, having developed innovative diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes.

Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time.


MeMed, Ltd.

Company Details